Marie Maxime Hubert Email & Phone Number

Ottawa, On, Ca

Recipient of the 2021 Exemplary AwardActing Director, Regulatory Affairs & Outreach (short-term)Role Summary: Operationalize the patented medicines pricing guidelines and their modernization

Ottawa, Canada Area

Role Summary: identify synergies to be leveraged in current or future partnerships, provide guidance on market access, health economics & outcomes researchResponsibilities included:-Identify groups that may benefit from the JSS expertise as CRO and explore synergies from renewed or initial collaborations-Coordinate internally to produce work assessments, proposals and legal agreements-Provide guidance to the market access HEOR unit

Role Summary: Build and manage consulting services globally with a team of health economists, for the development of reimbursement submissions, assessment of instruments and validation with key opinion leadersResponsibilities included:-Hire and train six health economists of various levels-Ensure the success of the mandates -Act as subject matter expert in stakeholder meetings (including Ministries of health, HTA bodies, academia and key opinion leaders) Therapeutic areas included:-hepatocellular carcinoma (HCC)-metastatic colorectal cancer (mCRC)-prostate cancer-management of pleural effusions & ascites-diabetes & blood glucose self-monitoring-male hypogonadism-thyroid disorders-end stage renal disease & serum phosphate management-cardiovascular (thrombolysis of pulmonary embolism)

Role Summary: Project manager overseeing the reimbursement dossier of a cancer drug for a multinational pharmaceutical companyResponsibilities include:-Oversee the progress of a cost-utility evaluation, budget impact analyses and costing model-Emphasize the attractiveness of a new oncology treatment to obtain a reimbursement recommendation from the pan-Canadian Oncology Drug Review (pCODR)-Support the team, develop their skills and knowledge

Ottawa, Ontario

Role Summary: Assist in the evaluation of medication for reimbursement by Canadian public drug plans by reporting on their cost-effectivenessRole consisted in:-critically appraise economic evaluations as part of the Common Drug Review (CDR) process, which provides Canadian provinces and territories with reimbursement recommendations -interact with the Canadian Drug Expert Committee (CDEC) to provide clarifications as part of CDR-perform re-analyses of economic models to illustrate the impact of key assumptions-draft reports following a rigorous structure, adapted to various audiences-develop methodologies for ad-hoc analyses

Montreal. Quebec

Role summary: Demonstrate the value of biologic anti-inflammatory medication adalimumab (Humira) in order to improve patient access (with reimbursement or optimal prescribing)Role consisted in: -Oversee the progress of projects performed by internal and external suppliers-Identify opportunities to promote drugs' cost-effectiveness to physicians-Implement the use of an economic model as a tool to demonstrate drugs' values -Adapt budget impact models and economic evaluations for Canadian reimbursement needs-Forecast financial opportunities to support listing agreements-Foster the growth of the market access team by identifying areas of improvement and organizing trainingTherapeutic areas:-biologics (Humira, adalimumab)-rheumatology (juvenile idiopathic arthritis, rheumatoid arthritis, etc)-dermatology (psoriasis, psoriatic arthritis)-gastroenterology (Crohn's disease)

Role summary: Provide pharmaceutical companies, drug insurers and pharmacies with insight on real world evidence, healthcare trends, budget and cost-effectiveness assessments for multiple drugs and therapeutic areasRole consisted in:-Evaluate client needs for analyses and determine their feasibility, considering IMS Brogan's databases and the team's resources-Develop methodologies and evaluate budgets, both incorporated in proposals-Depending on the complexity of the analysis, lead multidisciplinary teams (i.e programmer, clinical analyst), perform data extraction and synthesis, develop models, interpret results, write reports-Present findings to clients or stakeholders, address additional business needs with on-the-spot data analysisAnalyses included:-Pharmacoeconomic evaluations-Budget Impact Assessments (with interactive models)-Compliance analysis (fully customized)-Canadian Health Policies-Legal Implications of Subsequent-Entry Biologics

Role summary: Support different departments of the pharmaceutical company in the launch of dronedarone (Multaq) for the management of atrial fibrillation (irregular heart rhythms). The role consisted in:-Participate in the launch of the new chemical entity by elaborating a rationale for the choice of comparators of the pharmacoeconomic analysis-Review the pharmacoeconomic evaluation and suggest improvements-Assist market access and pricing research with data analysis-Perform a literature search on the comparator's safety and present to the Medical Science Liaison (MSL) team-Develop Medical Information (MedInfo) letters on expected questions from physicians related to the launch of the new chemical entity-Review a product monograph and participate in its finalization-Assist a Clinical Research Associate (CRA) in a routine visit to a hospital site

M.Sc., Pharmaceutical Sciences, Pharmacoeconomics

Graduate Diploma, Drug Development, Double Specialization In Pharmacoeconomics And Epidemiology

B.Sc., Biomedical Sciences